WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011140249) ANTIBODIES THAT BIND CSF1R
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/140249    International Application No.:    PCT/US2011/035231
Publication Date: 10.11.2011 International Filing Date: 04.05.2011
IPC:
A61K 39/395 (2006.01), C07K 16/00 (2006.01), C07H 21/04 (2006.01)
Applicants: FIVE PRIME THERAPEUTICS, INC. [US/--]; Two Corporate Drive South San Francisco, CA 94080 (US) (For All Designated States Except US).
WONG, Justin [US/US]; (US) (For US Only).
VASQUEZ, Maximiliano [US/US]; (US) (For US Only)
Inventors: WONG, Justin; (US).
VASQUEZ, Maximiliano; (US)
Agent: SCARR, Rebecca, B.; Casimir Jones, S.C. 2275 Deming Way, Suite 310 Middleton, WI 53562 (US)
Priority Data:
61/331,177 04.05.2010 US
Title (EN) ANTIBODIES THAT BIND CSF1R
(FR) ANTICORPS LIANT CSF1R
Abstract: front page image
(EN)Antibodies that bind CSF1 R are provided. Antibody heavy chains and light chains that are capable of forming antibodies that bind CSF1R are also provided. Polynucleotides encoding antibodies to CSF1R are provided. Polynucleotides encoding antibody heavy chains and lights chains are also provided. Methods of treatment using antibodies to CSF1R are provided. Such methods include, but are not limited to, methods of treating rheumatoid arthritis, bone loss, and multiple sclerosis.
(FR)La présente invention concerne des anticorps liant CSF1R ; des chaînes lourdes et des chaînes légères d'anticorps capables de former des anticorps liant CSF1R ; des polynucléotides codant pour des anticorps dirigés contre CSF1R ; des polynucléotides codant pour des chaînes lourdes et des chaînes légères d'anticorps ; et des méthodes de traitement utilisant des anticorps dirigés contre CSF1R. Lesdites méthodes comprennent, par exemple, mais la liste n'est pas limitative, des méthodes de traitement de la polyarthrite rhumatoïde, de la perte osseuse et de la sclérose en plaques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)